Neorich Biopharma Tech Co Limited (NRBP) Stock Price & Analysis

60 Followers

NRBP Stock Chart & Stats

$0.88$0.00(3.53%)

At close: Nov 10 4:00 PM EST

Day’s Range: $0.88 - $0.88
52-Week Range: $0.13 - $1.20
Previous Close: $0.85
Volume: N/A
Average Volume (3M): 684
Market Cap: $293.82K
Enterprise Value: $722.72B
Total Cash (Recent Filing): $721
Total Debt (Recent Filing): $355.59K
Price to Earnings (P/E): ―
Beta: 0.70
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Reduced Cash Burn

The sharp reduction in operating cash outflow shows some progress in controlling cash consumption, even though operations remain cash negative. If maintained, this improvement could extend liquidity and give the company more time to stabilize its business model.

Positive Reported Net Income

A positive reported net income provides evidence that the company can produce accounting earnings under some conditions. However, its durability is limited because operating results were deeply negative, so this benefit would need support from improving core profitability and cash conversion.

Reported Revenue Growth

The reported revenue-growth metric indicates a potentially significant change in the company’s top-line trajectory. Because the underlying revenue base is extremely small and the latest statement shows lower revenue, this is only a tentative positive rather than evidence of established scale.

Bears Say

Minimal Scale And Weak Profitability

Extremely low revenue and deeply negative operating results indicate that the core business has not yet demonstrated commercial scale or sustainable unit economics. The negative gross profit further weakens confidence that current operations can support durable earnings without major improvement.

Severely Stressed Balance Sheet

Negative equity and debt that is many times the asset base signal severe financial strain and limited balance-sheet flexibility. This structure can constrain investment in the business, increase dependence on external funding, and leave the company vulnerable to solvency pressure.

Persistent Negative Cash Flow

Repeated operating and free-cash-flow deficits show that the company is not currently self-funding its activities. Continued cash consumption can require additional financing and may limit the resources available for product development, commercialization, and other long-term priorities.

NRBP FAQ

What was Neorich Biopharma Tech Co Limited’s price range in the past 12 months?

Neorich Biopharma Tech Co Limited lowest stock price was $0.13 and its highest was $1.20 in the past 12 months.

What is Neorich Biopharma Tech Co Limited’s market cap?

Neorich Biopharma Tech Co Limited’s market cap is $293.82K.

When is Neorich Biopharma Tech Co Limited’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Is Neorich Biopharma Tech Co Limited overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Neorich Biopharma Tech Co Limited pay dividends?

Neorich Biopharma Tech Co Limited does not currently pay dividends.

What is Neorich Biopharma Tech Co Limited’s EPS estimate?

Neorich Biopharma Tech Co Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Neorich Biopharma Tech Co Limited have?

Neorich Biopharma Tech Co Limited has 345,673 shares outstanding.

Which hedge fund is a major shareholder of Neorich Biopharma Tech Co Limited?

Currently, no hedge funds are holding shares in NRBP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description